Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 19, 2025 • 2:21 PM ET

Date/Time Source News Release
05/12/2022 09:00 AM EDT ACCESSWIRE Medifocus, Inc. Announces SEC Deregistration
08/21/2020 05:39 PM EDT GlobeNewswire Medifocus Inc. Announces Resignation of Chief Financial Officer
07/24/2020 05:07 PM EDT GlobeNewswire Medifocus Inc. Announces Delayed Filing of Annual Disclosure Documents Pursuant to OSC Instrument 51-502
08/29/2019 09:03 AM EDT Newsfile Medifocus, Inc. Announces Increase in Revenue and Positive Cash Flow from Operation in Fiscal Year Ended March 31, 2019 and Global Market Expansion with Prolieve(R) Procedures Performed in Singapore
01/03/2019 09:15 AM EST GlobeNewswire Medifocus, Inc. Announces Global Market Expansion with Prolieve® Performed and Reimbursed by Insurance Carriers in Hong Kong
12/27/2018 09:15 AM EST GlobeNewswire Medifocus, Inc. Announces Recent Publication Highlighting Its Focal Therapy for Prostate and Breast Cancer Treatment Initiatives
12/10/2018 08:29 AM EST GlobeNewswire Uptick Newswire's Stock Day Podcast Hosts Medifocus, Inc.'s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers
12/03/2018 09:10 AM EST GlobeNewswire Medifocus, Inc. Announces FDA PMA Supplement Approval for New Labeling Based on Successful Completion of FDA Post Approval Study (PAS) for the Prolieve® Thermodilatation(TM) Device
11/29/2018 09:00 AM EST ACCESSWIRE Medifocus, Inc. Submits For New Patent Titled "Thermodilatation and Thermocompression to Facilitate Targeted Cluster Tissue Ablation and Immune Response"
11/27/2018 09:15 AM EST ACCESSWIRE Medifocus, Inc. Announces 26% Increase in Revenue in Recent Quarter and Positive Cash Flow from Operation for the Six Months Ended Sept 30, 2018
Page

Additional News

As of June 19, 2025 • 2:21 PM ET

Date/Time Source News Release
12/03/2018 12:20 PM EST Baystreet Medifocus Climbs on Winning FDA Nod
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.